Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Recombinant subunit vaccines.

W N Burnette1

  • 1Amgen Inc., Thousand Oaks, California.

Current Opinion in Biotechnology
|December 1, 1991
PubMed
Summary

Advancements in recombinant DNA technology are driving innovation in vaccine development. This research enhances understanding of immune responses and improves vaccine design and delivery methods.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Bacterial ADP-ribosylating toxins: form, function, and recombinant vaccine development.

Behring Institute Mitteilungen·1997
Same author

Parameters for the rational design of genetic toxoid vaccines.

Advances in experimental medicine and biology·1996
Same author

Molecular engineering of cholera toxin.

Advances in experimental medicine and biology·1995
Same author

Human antibody response to the B oligomer of pertussis toxin.

Clinical and diagnostic laboratory immunology·1994
Same author

Construction and characterization of recombinant Vibrio cholerae strains producing inactive cholera toxin analogs.

Infection and immunity·1994
Same author

AB5 ADP-ribosylating toxins: comparative anatomy and physiology.

Structure (London, England : 1993)·1994

Area of Science:

  • Biotechnology and immunology
  • Vaccine development and molecular biology

Background:

  • Recombinant DNA technology offers a powerful platform for novel vaccine creation.
  • Significant progress has been made in understanding the complexities of vaccine-induced immune responses.

Purpose of the Study:

  • To explore the broad applications of recombinant DNA in vaccine research.
  • To enhance the rational design of immunogens for improved efficacy.
  • To investigate novel vaccine delivery systems.

Main Methods:

  • Utilizing recombinant DNA techniques for antigen production.
  • Conducting immunological studies to assess vaccine responsiveness.
  • Developing and evaluating new vaccine delivery strategies.

Main Results:

  • Increased knowledge of immunological responses to vaccine candidates.
  • Successful rational engineering of immunogens.
  • Development of innovative vaccine delivery mechanisms.

Conclusions:

  • Recombinant DNA technology is a key driver in modern vaccine research.
  • Improved understanding of immunology facilitates better vaccine design.
  • Novel delivery systems promise enhanced vaccine efficacy and accessibility.

Related Experiment Videos